Disclaimers

Certain information set forth in this presentation contains "forward-looking information", including, but not limited to, "potential penetration statements" and "assumptions", under applicable securities laws (collectively referred to herein as forward-looking statements). Except for statements of historical fact, all information contained herein constitutes forward-looking statements and includes, but is not limited to, the expected development of MMH's business.

These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements.

There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. MMH undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change. The reader is cautioned not to place reliance on forward-looking statements.

MMH makes no representation or warranty to any prospective investor with respect to the forward-looking statements. With respect to these statements made available by or on behalf of MMH to prospective investors, each prospective investor acknowledges that: (a) there are uncertainties inherent in attempting to make such statements, (b) such investor is familiar with such uncertainties, (c) such investor takes full responsibility for making its own evaluation of the adequacy and accuracy of all information provided, and (d) prospective investors shall have no claim against MMH, including its officers, directors and legal and financial representatives, whatsoever based upon the inaccuracy of any information contained in this document.


The Problems That Drive Our Solution

MSK pain statistics

Growing MSK Costs

Acute and chronic MSK conditions are rapidly growing cost areas with limited preventative care focus in the U.S. healthcare system.

Fragmented care data

Fragmented Systems

Lack of comprehensive risk screening, fragmented data/systems, and high-cost specialty care interventions after the patient is injured.

Performance barriers

Performance Barriers

Direct barrier to optimal athletic performance and military readiness. High-cost interventions after injuries occur.

Current Problem

Acute and chronic MSK conditions are rapidly growing cost areas

Limited preventative care focus in the U.S. health care system

Lack of comprehensive risk screening, fragmented data/systems

High-cost, specialty care interventions after the patient is injured

Direct barrier to optimal athletic performance & military readiness

Our Solution

MMH created a novel and automated MSK assessment technology

Combines comprehensive virtual data collection with cutting-edge analytical AI

Removed administrative and data integration barriers impeding optimized preventive care and personalized interventions

Platform poised to scale; no regulatory approval risk impeding GTM adoption


Provide Technology to Improve MSK Care

  • Analytic platform that empowers providers with AI enhanced MSK assessments, streamlined evaluations, early detection of injury risk factors, and automation of administrative tasks
  • Virtual care through provider-led telemedicine encounter or EMMA patient-directed Bot
  • Mapped therapies with over 350 AI-supported exercises
MyMedicalHub technology platform architecture
MyMedicalHub platform overview showing data flow and integrations

AI-Powered Computer Vision Platform

  • Automate the collection of over 1,000 data points including 60 orthopedic movements and provocative pain tests
  • Virtual Medical Assistant "EMMA" automates entire assessment process using Bot technology
  • Advanced machine learned algorithms quantify a patient's MSK risk
  • Integrated ChatGPT tenant to organize, track, and report meaningful clinical data in a concise, user-friendly format for reporting and practice automation
AI-powered computer vision assessment interface

MyMedicalHub patent portfolio overview

Patented Technology

  • MMH patents will create significant competitive barriers for virtual MSK evaluations
  • Notice of Allowance issued for GAIT/Fall Risk and Back
  • Patents pending for Cervical, Upper Extremities, Lower Extremities
View All Patents

Total Addressable US Market

One Trillion Dollars

Consumer Athletics / Youth Sports

Performance optimization, injury prevention. 2.6B registered athletes globally. $40 billion spent annually by parents.

Providers

Clinical assessments, early interventions. 3,300 retail clinics. 229,000 primary care. 300,000 MSK specialty providers.

DOD / SOCOM / VA / NASA

Field readiness, injury mitigation. 10 million lives in military (1.8M active, 12.2M veterans).

Health Plans & Employers

Cost control, workplace wellness. 300 million lives. 100 million MSK patients.

MMH Opportunity With Potential Penetration Assumptions Is Over $1 Billion Per Year

Market opportunity breakdown chart Market opportunity breakdown chart

Consumer Athletics/Youth Sports — 0.5% Penetration: 2.6B registered participants @$35 per assessment = $455,000,000

DOD/SOCOM/VA TAMPA — 100% Penetration: Human Performance @$35 per assessment = $126,000,000 (2 assessments per year)

Providers — 1% Penetration: 30,000 MSK and 2,900 Primary Care @$35 per assessment = $690,000,000 per year (600 assessments per provider per year)

Health Plans — 1% Penetration: One million patients @$300 per year = $300,000,000


A Proven Growth Sector

The musculoskeletal (MSK) health market has proven to be one of the fastest-growing sectors in digital health, with several platforms reaching multi-billion-dollar valuations.

While many companies in this space focus on high-barrier channels such as insurers and large employers, MyMedicalHub (MMH) takes a unique approach — proving value first through direct-to-consumer, athlete, and veteran populations.

Our AI-driven assessments, longitudinal health tracking, and digital therapeutics can be accessed from any smart device — empowering users, providers, and institutions to make more informed decisions and drive better outcomes.

MMH's ability to scale across B2C, B2B, and government channels simultaneously — supported by patented technology and a modular architecture — positions the platform for rapid adoption and long-term impact.

Key Investors & Advisors

Dr. Raquel Bono

Vice Admiral and former CEO Defense Health Agency

Dr. Joyce Nuesca

Former Regional Medical Director Blue Shield of California

Kiki VanDeWeghe

Former COO National Basketball Association

Bill Lucia

Former CEO HMS

Edgar Rios

Co-Founder/Executive VP General Counsel of Americhoice (Acquired by UHG)

Frank Sheehy

Former CEO Envision Rx (acquired by RiteAid)

Dr. David Ring

Associate Dean and Professor Dell Medical School, double board-certified in orthopedic surgery and psychiatry

Dr. Michael Dougals

Assistant Professor of Kinesiology and Health Sciences, Chair of Department, Morehouse College

Interested in Learning More?

Contact us to learn about investment opportunities and how MyMedicalHub is transforming the musculoskeletal healthcare market.

Contact Us